Worse PFS Seen with Nivolumab-Rucaparib in Ovarian Cancer

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.
Medscape Medical News

source https://www.medscape.com/viewarticle/nivolumab-rucaparib-not-superior-rucaparib-maintenance-tx-2024a1000gq5?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?